{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_furosemide",
          "name": "Furosemide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "name": "Angiotensin II receptor blockers"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_complement_inhibitors",
          "name": "Complement inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_steroids",
          "name": "Steroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_dialysis",
          "name": "Dialysis"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_supportive_care",
          "name": "Supportive care"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_furosemide",
          "type": "Drug",
          "label": "Furosemide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "type": "Drug",
          "label": "Angiotensin II receptor blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitors",
          "type": "Drug",
          "label": "Complement inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_steroids",
          "type": "Drug",
          "label": "Steroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dialysis",
          "type": "Drug",
          "label": "Dialysis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_supportive_care",
          "type": "Drug",
          "label": "Supportive care",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg1",
          "type": "Target",
          "label": "Complement system",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg2",
          "type": "Target",
          "label": "Kidney function regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Complement activation pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Renal function pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知抑制补体活化"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "类似于Eculizumab，补体抑制"
        },
        {
          "source": "drug_furosemide",
          "target": "n_tg2",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常用于调节肾脏功能"
        },
        {
          "source": "drug_angiotensin_ii_receptor_blockers",
          "target": "n_tg2",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知影响肾功能"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有免疫抑制作用，可能影响病理"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于移除补体成分"
        },
        {
          "source": "drug_complement_inhibitors",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接靶向补体系统"
        },
        {
          "source": "drug_steroids",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于减轻炎症反应"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "n_tg1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "作为免疫抑制剂可能相关"
        },
        {
          "source": "drug_anticoagulants",
          "target": "n_tg2",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能影响血液流动性"
        },
        {
          "source": "drug_dialysis",
          "target": "n_tg2",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于肾功能替代治疗"
        },
        {
          "source": "drug_supportive_care",
          "target": "n_tg2",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "旨在改善整体状况"
        },
        {
          "source": "n_tg1",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "补体系统激活是多个病理通路的基础"
        },
        {
          "source": "n_tg2",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影響腎功能的通路"
        },
        {
          "source": "n_pathway1",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "补体激活与该病相关"
        },
        {
          "source": "n_pathway2",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "肾脏功能障碍促进症状发展"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过靶向补体系统或肾功能影响Atypical haemolytic uraemic syndrome的进程",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物可以有效到达相关组织的最小暴露（基于药理常识）"
    ],
    "uncertainties": [
      "各药物之间效果的相对优劣尚需进一步验证"
    ],
    "next_focus_for_pi": [
      "是否需要追加其他药物作为潜在选择？"
    ]
  }
}